Clinical Pharmacokinetics

Integrated Pharmacokinetics and Pharmacodynamics in Drug Development
pp. 713-737(25)
Authors: Dingemanse, Jasper; Appel-Dingemanse, Silke

Clinical Pharmacokinetics of Darunavir
pp. 739-756(18)
Authors: Rittweger, Michael; Arastéh, Keikawus

Phase I Evaluation of the Safety, Pharmacokinetics and Pharmacodynamics of CP-481,715
pp. 757-766(10)
Authors: Clucas, Alan T.; Shah, Ajit; Zhang, Yuanchao Derek; Chow, Vincent F.; Gladue, Ronald P.

Pharmacokinetics and Tolerability of Duloxetine following Oral Administration to Healthy Chinese Subjects
pp. 767-775(9)
Authors: Tianmei, Si; Mary Pat Knadler,; Lim, Ming T.; Kwee Poo Yeo,; Teng, Leyan; Liang, Shu; Pan, Alan X.; Lobo, Evelyn D.

Increased Absorption of Digoxin from the Human Jejunum Due to Inhibition of Intestinal Transporter-Mediated Efflux
pp. 777-785(9)
Authors: Igel, Svitlana; Drescher, Siegfried; Mürdter, Thomas; Hofmann, Ute; Heinkele, Georg; Tegude, Heike; Glaeser, Hartmut; Brenner, Stefanie S.; Somogyi, Andrew A.; Omari, Taher; Schäfer, Christian; Eichelbaum, Michel; Fromm, Martin F.

The Absolute Oral Bioavailability and Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers
pp. 787-802(16)
Authors: He, Yan-Ling; Sadler, Brian M.; Sabo, Ron; Balez, Sebastien; Wang, Yibin; Campestrini, Joelle; Laurent, Aziz; Ligueros-Saylan, Monica; Howard, Dan

Thiopurine Treatment in Inflammatory Bowel Disease
pp. 803-804(2)
Authors: Gardiner, Sharon J.; Begg, Evan J.; Sau, Ashis; Marinaki, Anthony; Gearry, Richard B.; Barclay, Murray L.

The Authors' Reply
pp. 805-805(1)
Author: Matthias Schwab on behalf of all authors,